|
1
|
Raghunath A, Sundarraj K, Arfuso F, Sethi
G and Perumal E: Dysregulation of nrf2 in hepatocellular carcinoma:
Role in cancer progression and chemoresistance. Cancers (Basel).
10:E4812018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Z, Zhang Y, Wang Y, Xu L and Xu W:
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate
biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular
carcinoma. Onco Targets Ther. 9:123–129. 2015.PubMed/NCBI
|
|
3
|
Schuette D, Moore LM, Robert ME, Taddei TH
and Ehrlich BE: Hepatocellular carcinoma outcome is predicted by
expression of neuronal calcium sensor 1. Cancer Epidemiol
Biomarkers Prev. 27:1091–1100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hernandez-Gea V, Turon F, Berzigotti A and
Villanueva A: Management of small hepatocellular carcinoma in
cirrhosis: Focus on portal hypertension. World J Gastroenterol.
19:1193–1199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang W and You J: Research and application
of (18)F-fluorodeoxyglucose positron emission tomography/computed
tomography for the diagnosis and treatment of primary
hepatocellular carcinoma. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi.
34:480–484. 2017.(In Chinese; Abstract available in Chinese from
the publisher). PubMed/NCBI
|
|
9
|
Guo W, Tan HY, Wang N, Wang X and Feng Y:
Deciphering hepatocellular carcinoma through metabolomics: From
biomarker discovery to therapy evaluation. Cancer Manag Res.
10:715–734. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ressom HW, Xiao JF, Tuli L, Varghese RS,
Zhou B, Tsai TH, Ranjbar MR, Zhao Y, Wang J, Di Poto C, et al:
Utilization of metabolomics to identify serum biomarkers for
hepatocellular carcinoma in patients with liver cirrhosis. Anal
Chim Acta. 743:90–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Fan SF, Wang Y, Shen SG and Sun DX:
Rapid detection of small molecule metabolites in serum of
hepatocellular carcinoma patients using ultrafast liquid
chromatography-ion trap-time of flight tandem mass spectrometry.
Anal Sci. 33:573–578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang A, Sun H, Yan G, Han Y, Ye Y and
Wang X: Urinary metabolic profiling identifies a key role for
glycocholic acid in human liver cancer by ultra-performance
liquid-chromatography coupled with high-definition mass
spectrometry. Clin Chim Acta. 418:86–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li QF, Zhan YM, Zhong YG, Zhang B and Ge
CQ: Macromolecular crowding agents-assisted imprinted polymers for
analysis of glycocholic acid in human plasma and urine. Biomed
Chromatogr. 30:1706–1713. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martinot E, Sedes L, Baptissart M,
Lobaccaro JM, Caira F, Beaudoin C and Volle DH: Bile acids and
their receptors. Mol Aspects Med. 56:2–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui X, Vasylieva N, Shen D, Barnych B,
Yang J, He Q, Jiang Z, Zhao S and Hammock BD: Biotinylated
single-chain variable fragment-based enzyme-linked immunosorbent
assay for glycocholic acid. Analyst. 143:2057–2065. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo C, Xie C, Ding P, Qin G, Mo W, Cao X
and Zheng S: Quantification of glycocholic acid in human serum by
stable isotope dilution ultra performance liquid chromatography
electrospray ionization tandem mass spectrometry. J Chromatogr B
Analyt Technol Biomed Life Sci. 1072:315–319. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo L, Schomaker S, Houle C, Aubrecht J
and Colangelo JL: Evaluation of serum bile acid profiles as
biomarkers of liver injury in rodents. Toxicol Sci. 137:12–25.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trottier J, Bialek A, Caron P, Straka RJ,
Milkiewicz P and Barbier O: Profiling circulating and urinary bile
acids in patients with biliary obstruction before and after biliary
stenting. PLoS One. 6:e220942011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao JF, Varghese RS, Zhou B, Nezami
Ranjbar MR, Zhao Y, Tsai TH, Di Poto C, Wang J, Goerlitz D, Luo Y,
et al: LC-MS based serum metabolomics for identification of
hepatocellular carcinoma biomarkers in egyptian cohort. J Proteome
Res. 11:5914–5923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmid A, Neumann H, Karrasch T, Liebisch
G and Schaffler A: Bile acid metabolome after an oral lipid
tolerance test by liquid chromatography-tandem mass spectrometry
(Lc-Ms/Ms). PLoS One. 11:e01488692016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui X, Vasylieva N, Wu P, Barnych B, Yang
J, Shen D, He Q, Gee SJ, Zhao S and Hammock BD: Development of an
indirect competitive enzyme-linked immunosorbent assay for
glycocholic acid based on chicken single-chain variable fragment
antibodies. Anal Chem. 89:11091–11097. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hua J, Li Z, Xia W, Yang N, Gong J, Zhang
J and Qiao C: Preparation and properties of EDC/NHS mediated
crosslinking poly (gamma-glutamic acid)/epsilon-polylysine
hydrogels. Mater Sci Eng C Mater Biol Appl. 61:879–892. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schrama D, Reisfeld RA and Becker JC:
Antibody targeted drugs as cancer therapeutics. Nat Rev Drug
Discov. 5:147–159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumar G: Fungal laccase efficiently
destains coomassie brilliant blue-R-250 stained polyacrylamide
gels. Methods Mol Biol. 1853:247–253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. The
National Academies Collection: Reports funded by National
Institutes of Health (8th). (Washington (DC), USA). 2011.
|
|
26
|
Seong GS, Sohn HJ, Kang H, Seo GE, Kim JH
and Shin HJ: Production and characterization of monoclonal
antibodies against cathepsin B and cathepsin B-Like proteins of
naegleria fowleri. Exp Parasitol. 183:171–177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kohler G and Milstein C: Continuous
cultures of fused cells secreting antibody of predefined
specificity. Nature. 256:495–497. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim JH, Lee J, Sohn HJ, Song HO, Kim JY,
Lee WJ, Park H and Shin HJ: Production of monoclonal antibodies for
Plasmodium vivax lactate dehydrogenase and patient sera screening
using sandwich ELISA. Parasitol Res. 111:1645–1650. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Q, Qiu S, Li H, Lin C, Luo Y, Ren W,
Zou Y, Wang Y, Xia N and Huang C: A novel approach for rapid
high-throughput selection of recombinant functional rat monoclonal
antibodies. BMC Immunol. 19:352018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zarei S, Bayat AA, Hadavi R, Mahmoudi AR,
Tavangar B, Vojgani Y, Jeddi-Tehrani M and Amirghofran Z:
Production and characterization of a peptide-based monoclonal
antibody against CD44 variant 6. Monoclon Antib Immunodiagn
Immunother. 34:36–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sheng JW, He M and Shi HC: A highly
specific immunoassay for microcystin-LR detection based on a
monoclonal antibody. Anal Chim Acta. 603:111–118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin Z, Sun T, Xia X, Wei Q, Song Y, Han Q,
Chen Q, Hu J and Zhang J: Optimized expression, purification of
herpes B virus gD protein in escherichia coli, and production of
its monoclonal antibodies. Jundishapur J Microbiol. 9:e321832016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aghebati Maleki L, Majidi J, Baradaran B,
Abdolalizadeh J, Kazemi T, Aghebati Maleki A and Sineh Sepehr K:
Large scale generation and characterization of anti-human CD34
monoclonal antibody in ascetic fluid of balb/c mice. Adv Pharm
Bull. 3:211–216. 2013.PubMed/NCBI
|
|
34
|
Yin W, Liu J, Zhang T, Li W, Liu W, Meng
M, He F, Wan Y, Feng C, Wang S, et al: Preparation of monoclonal
antibody for melamine and development of an indirect competitive
ELISA for melamine detection in raw milk, milk powder, and animal
feeds. J Agric Food Chem. 58:8152–8157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen L, Wang L, Yan J, Ma C, Lu J, Chen G,
Chen S, Su F, Wang W and Su X: 131I-labeled monoclonal antibody
targeting neuropilin receptor type-2 for tumor SPECT imaging. Int J
Oncol. 50:649–659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maragos CM, Busman M and Plattner RD:
Development of monoclonal antibodies for the fusarin mycotoxins.
Food Addit Contam Part A Chem Anal Control Expo Risk Assess.
25:105–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He Q, Cui X, Shen D, Chen Y, Jiang Z, Lv
R, Eremin SA and Zhao S: Development of a simple, rapid and
high-throughput fluorescence polarization immunoassay for
glycocholic acid in human urine. J Pharm Biomed Anal. 158:431–437.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Collazos J: Glycocholic acid in chronic
active hepatitis and mild liver diseases. Clin Investig. 72:36–39.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li T and Chiang JY: Bile Acid signaling in
liver metabolism and diseases. J Lipids. 2012:7540672012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim MJ and Suh DJ: Profiles of serum bile
acids in liver diseases. Korean J Intern Med. 1:37–42. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou L, Wang SB, Chen SG, Qu Q and Rui JA:
Prognostic value of ALT AST, and AAR in hepatocellular carcinoma
with B-type hepatitis-associated cirrhosis after radical
hepatectomy. Clin Lab. 64:1739–1747. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stepien M, Fedirko V, Duarte-Salles T,
Ferrari P, Freisling H, Trepo E, Trichopoulou A, Bamia C,
Weiderpass E, Olsen A, et al: Prospective association of liver
function biomarkers with development of hepatobiliary cancers.
Cancer Epidemiol. 40:179–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song WS, Park HM, Ha JM, Shin SG, Park HG,
Kim J, Zhang T, Ahn DH, Kim SM, Yang YH, et al: Discovery of
glycocholic acid and taurochenodeoxycholic acid as phenotypic
biomarkers in cholangiocarcinoma. Sci Rep. 8:110882018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Collazos J, Mendarte U and De Miguel J:
Clinical value of the determination of fasting glycocholic acid
serum levels in patients with liver diseases. A comparison with
standard liver tests. Gastroenterol Clin Biol. 17:79–82.
1993.PubMed/NCBI
|
|
45
|
Li X, Yang L, Yang Y, Shao M and Liu Y:
Preparation and characterization of a novel monoclonal antibody
against the extracellular domain of human transferrin receptor.
Monoclon Antib Immunodiagn Immunother. 36:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Han J, Qin WX, Li ZL, Xu AJ, Xing H, Wu H,
Zhang H, Wang MD, Li C, Liang L, et al: Tissue and serum metabolite
profiling reveals potential biomarkers of human hepatocellular
carcinoma. Clin Chim Acta. 488:68–75. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng
X, Qi X, Cao Y, Su M, Wang X, et al: Serum and urine metabolite
profiling reveals potential biomarkers of human hepatocellular
carcinoma. Mol Cell Proteomics. 10:M110004945. 2011. View Article : Google Scholar
|
|
48
|
Thjodleifsson B, Barnes S, Chitranukroh A,
Billing BH and Sherlock S: Assessment of the plasma disappearance
of cholyl'l14C-glycine as a test of hepatocellular disease. Gut.
18:697–702. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
McCormick WC III, Bell CC Jr, Swell L and
Vlahcevic ZR: Cholic acid synthesis as an index of the severity of
liver disease in man. Gut. 14:895–902. 1973. View Article : Google Scholar : PubMed/NCBI
|
